dihexa study Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents DIHEXA is changing the conversation
Description
C., Liao Y
Systemic administration, like a subcutaneous injection, allows the peptide to circulate throughout the body to act on an injury
State Medicaid Coverage of GLP-1s for Obesity Treatment (as of August 2024) KFF found that as of August 2024, 13 state Medicaid programs covered GLP-1s for obesity treatment within their fee-for-service programs
When an intensive diet and exercise regime was incorporated into the study design, the peptides weight loss signal essentially disappeared versus the control group
